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Reduction of Lipid Peroxidation in Reperfused Isolated Rabbit Hearts by Diltiazem
Patrick T. Koller and Steven R. Bergmann
The calcium-channel inhibiting agent, diltiazem, has been shown to enhance salvage of reperfused myocardium independent of effects on coronary blood flow or myocardial work. Because lipid peroxidation may be a mediator of reperfusion injury and modifiable by calcium-sensitive pathways, we evaluated the effects of diltiazem on the formation of malondialdehyde (MDA), a product of lipid peroxidation, in isolated rabbit hearts perfused with buffer under control conditions or after 60 minutes of ischemia with or without 3 minutes of reperfusion. Diltiazem (5xl0~7 M) reduced tissue MDA content in seven reperfused hearts compared with levels measured in 14 hearts reperfused without drug (1.54±1.09 [SD] compared with 3.57±1.88 nmol/g, p<0.05). Superoxide dismutase and catalase were ineffective in reducing tissue MDA content in reperfused hearts (n=8; MDA concentration, 3.88±2.82 nmol/g) although they were effective in preventing lipid peroxidation in separate studies in which oxygen-centered free radicals were generated directly by an infusion of xanthine oxidase and hypoxanthine. These results suggest that the salutary effects of diltiazem in the setting of reperfusion may be mediated by reduction of lipid peroxidation at a locus not accessible to scavengers of oxygen-centered free radicals or by a mechanism not mediated by free radical pathways. {Circulation Research 1989;65:838-846)
A cute interventions for treatment of myocardial ischemia are predicated on the evolutionary nature of infarction and the demonstration that myocardial reperfusion, when initiated early, can salvage myocardium. 1 -2 Calciumchannel inhibiting agents (blockers) have been shown to reduce infarct size when administered during ischemia alone 3 and more recently have been shown to enhance myocardial salvage elicited by reperfusion. 4 - 5 We have shown that diltiazem decreases infarct size even more than that attributable to reperfusion alone by a mechanism other than altered coronary blood flow or myocardial work, 6 factors known to affect infarct size.
It has been postulated that reperfusion elicits "reperfusion injury,"'A 7 that is, a reduction of the maxi-mum extent of myocardial salvage inducible by reflow, perhaps because of the formation of cytotoxic oxygencentered free radicals. 8 -13 Evidence for free radicalinduced tissue injury includes the protection afforded by use of specific scavengers of oxygen-centered free radicals 9 12 and the generation of free radicals in reperfused tissue detected by electron paramagnetic resonance (EPR) spectroscopy. 9 -13 However, in contrast to these studies, others have shown that oxygencentered free radical scavengers fail to reduce infarct size. 14 -15 In experimental animals, the size of infarction after acute occlusion and reperfusion can be quite variable and is influenced by multiple potentially confounding factors including ventricular loading conditions, myocardial work, and collateral blood flow, among others. 1617 Direct evidence of oxygencentered free radical generation by EPR spectroscopy has been recently questioned as potentially reflecting artifact. 18 Additionally, the identification of oxygencentered free radicals per se does not necessarily imply that their presence is responsible for toxic effects.
One pathway by which oxygen-centered free radicals may induce toxic effects is through initiation of membrane lipid peroxidation. Lipid peroxidation alters membrane permeability and may induce deleterious effects. 19 Thus, some investigators have 
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where R is the universal gas constant, T is the absolute temperature, and F is the Faraday constant. Thus, if aNaj and Ca; do not change, then E r and the driving force on the exchanger (E r -E m ) for a given E m will be constant as long as the (aNa 0 ) 3 / aCao ratio is constant. When both [Na] o and [Ca] o are simultaneously reduced to 40 mM and 46 /u,M, respectively, maintaining a constant (aNajVaCa,, ratio*, the relaxation is almost the same as with caffeine alone ( Figure 6 , Table 2 ). This is consistent with the contention that in the presence of caffeine, relaxation is mainly controlled by a simple 3:1 Na-Ca exchanger.
Since relaxation is restored to normal by simultaneous Na,, and Ca,, reduction, this condition can serve as the control for potassium substitution experiments, which are illustrated in Figure 7 . The curve labeled 6K in Figure 7 is the same as the curve labeled 40 Na/.O4 Ca in Figure 6 . The other relaxation time courses in Figure 7 were obtained by replacing 10, 30, or 100 mM of the LiCl with KC1 in the cold and rewarming solutions (with 40 mM Na, 46 fiM Ca,* and 10 mM caffeine). Increasing *Contaminant calcium must be considered in micromolar calcium solutions. The solutions for this series of experiments were made up with 34 /uM added calcium, thus allowing a generous margin for contaminant calcium (12 /i.M, to give a total of 46 ixM calcium). This is likely to be higher than the actual contaminant calcium (which we typically measure to be ~3-6 (iM) but was chosen for the following two reasons: 1) During the 3-minute RCC, it is unlikely that interstitial [Ca] gets down as low as superfusate [Ca] (see above), but probably gets closer to [K] o (and consequent depolarization) slows relaxation substantially. Pooled results from six experiments like this are summarized in Table 2 , and Figure 8 shows the relaxation half-times for the different [K] and estimated E m values.
The apparent voltage dependence is steepest from -35 to -7 mV (the most positive potential used). This is expected since calculation of E r from Equation 1 (for aNaj=7.5 mM and [Ca]i=200 nM) yields -34 mV. Thus, relaxation is slowed as we depolarize toward E r for Na-Ca exchange and is more dramatically slowed above the expected E r . The fact that relaxation is not completely prevented by depolarization above E r suggests that some other means of relaxation is still functional.
When the muscle is depolarized by high [K] o , it is possible that non-inactivating voltage-dependent calcium channels (i.e., calcium window current) are opened such that a background calcium entry is slowing relaxation. To investigate this possibility, we repeated the experiments in Figure 7 with or superfusate [Na]. 26 The half-time for twitch-tension decline upon abrupt reduction of [Ca] in muscles of the size used here is typically about 15-30 seconds, and the interstitial [Ca] change may be extrapolated to be about 99% complete in 3 minutes. Thus, in some muscles the interstitial [Ca] may still be slightly higher than 46 /xM at the time of rewarming. 2) During long RCCs, it is likely that intracellular [Na] slowly rises due to sodium-pump inhibition. Indeed, after long RCCs (3-10 minutes), a transient inotropic effect is observed that resembles cardiac glycoside-induced inotropy. We can also estimate from Equation 3 that a 1 mM rise in aNa; (from 7.5 to 8.5 mM) could be compensated by reducing [Ca] 0 an additional 11 ju.M, and E r would still be unchanged. While these quantitative limitations must be kept in mind, we feel that the simple interpretation of the results stated in the text is correct (i.e., that in the presence of 10 mM caffeine, relaxation is largely determined by a 3:1 Na-Ca exchange). FIGURE Figure 6 and Figure 7 and Table 2 , but a similar protocol is used. without 10 yM nifedipine in the cold and rewarming solution. Inclusion of 10 juM nifedipine in the cold and rewarming solution was sufficient to reduce the post-RCC twitches by more than 95%. Nifedipine accelerated relaxation somewhat at high [K] but had no effect at lower [K] ( Figure 8 ). Thus there may be a small calcium current (with [Ca] 0 =46 yuM) in the higher [K] relaxations in Figure 7 and Figure  8 , but the conclusion is not changed.
Graph of relaxation half-times for rapid cooling contractures in the presence of 10 mM caffeine (circles) and sodium-free, calcium-free medium (squares), as a function of membrane potential (E m ), where E m is calculated assuming [K]j=140 mM and that E m is the same as the potassium reversal potential, E K . The rewarming relaxations were also repeated in the presence of 10 (iM nifedipine (open symbols and dotted curves). This set of experiments (nifedipine) is from a different group of six muscles than that used in
Relaxation in the absence of caffeine but in sodiumfree, calcium-free medium was insensitive to changes in E m in either the absence or presence of 10 /xM nifedipine (Figure 8 , Na-free). Thus, the relaxation in the absence of Na-Ca exchange (presumably due to SR calcium uptake) is not E m sensitive. This contrasts with the E m dependence of relaxation in the presence of caffeine (presumably due to Na-Ca exchange).
Discussion
Rapid cooling of mammalian cardiac muscle to 0-1° C causes a release of SR calcium that then activates a contraction (RCC) initially described by Kurihara and Sakai 9 and Bridge. 8 The amplitude of these RCCs is a useful indicator of releasable SR calcium in intact cardiac muscle, 8 -10 -12 -33 -34 which is a difficult quantity to assess. The transient increase in force upon rewarming (or rewarming spike) can be attributed to the warming-induced increase of myofilament calcium sensitivity observed in chemically skinned fibers. 13 In the present study, we have focused our attention on the relaxation observed after the peak of the rewarming spike. Relaxation under these circumstances should be due to the rapid reactivation of calcium transport systems that were inhibited at 0° C. There is undoubtedly temporal overlap between the rewarminginduced myofilament sensitization and calcium removal from the sarcoplasm. However, the point where tension begins to decline marks the time where calcium extrusion is the dominant process (and the myofilament sensitization may be nearly complete). Thus the time course of relaxation may provide information about the calcium movements responsible for relaxation, but at times near the peak of tension, the kinetics will be complicated by the myofilament sensitization and temperature inhomogeneity. Rewarming to 30° C is fast, but not instantaneous, and the final approach from 27°-30° C is the slowest phase. Thus, if there is a large difference in temperature sensitivity of the SR calcium pump and Na-Ca exchange, relaxation will appear more dependent on the process that is closer to its 30° C condition. We take advantage of the cold time to modify the ambient solution when relaxation is activated. These changes in solution have little effect on the RCC itself but can markedly change the time course of relaxation. In effect, we are using the RCC to hold the intracellular ionic conditions relatively constant with high [Ca]j while we modify the interstitial medium.
It may be noted that we are measuring the relaxation of force rather than calcium removal from the cytoplasm or myofilaments per se. We use the terms almost interchangeably to facilitate discussion, with the implicit assumption that these processes are specifically and closely related (although the relation can be modified by caffeine, see below). The time course of relaxation does not appear to vary much as a function of force or [Ca] f at the time of rewarming (e.g., see Figure 2 , Table 1 ). While this may suggest some functional characteristics of the calcium transport systems, for the present study we take advantage of this empirical finding simply so that we can compare relaxation time courses from different absolute force levels.
Sarcoplasmic Reticulum Calcium Pump and Na-Ca Exchange in Rapid Cooling Contracture Relaxation
A major conclusion of this study is illustrated in Figure 3 . That is, either the SR calcium accumulation (which is caffeine-sensitive) or, to a slightly lesser extent, the Na-Ca exchange (which is dependent on Na o ) can induce relaxation at nearly normal rates, but when both systems are inhibited, relaxation is dramatically slowed. This result suggests that the SR calcium pump and Na-Ca exchange are two main mechanisms responsible for relaxation and they may be expected to compete with each other. The extent of the competition between the SR calcium pump and Na-Ca exchange is difficult to quantitate from the present experiments. One reason for this difficulty is the complicating effect of caffeine increasing myofilament calcium sensitivity. 27 1,1,3,3,-tetramethoxypropane (Sigma). The minimal MDA concentration detectable was 0.1 nmol/ml (2.0 pmol/20 /tl sample). The recovery of MDA in tissue was assessed by adding a known amount of MDA to nonperfused tissue homogenates and processing these samples according to the protocol. Recovery averaged 93-97% (n=8 determinations). Tissue MDA peaks were identified by their coelution with added MDA standard (Figure 1 ). Chromatography was performed at reduced flow rates (0.1 ml/min) in selected samples from tissue to confirm coelution of tissue and standard peaks attributed to MDA. Tissue analysis was done in duplicate, and values agreed within 15%.
In preliminary studies we compared MDA content in tissue by the HPLC method used in this study with that measured using the colorimetric thiobarbituric acid (TBA) technique. Although there was a general correlation between the two assay methods (r=0.76, «=36; Figure 3 ), MDA content assayed by the TBA assay did not correlate well with the more specific HPLC technique at MDA . Plot of tissue malondialdehyde (MDA) content determined by high-performance liquid chromatography compared with the thiobarbituric acid (TBA) spectrophotometric assay. Although an overall correlation between the two methods can be observed, the correlation is not as strong at concentrations of less than 0.4 nmollml, which corresponds to a tissue content of approximately 4 nmollg after correction for dilution. values less than 0.4 nmol/ml. Therefore, we used the more specific HPLC method for measuring MDA in myocardial tissue.
Verification of Methods
To determine whether the HPLC procedure for measurement of MDA would be sensitive to oxygencentered free radical-initiated lipid peroxidation, we studied fourteen additional isolated perfused rabbit hearts with a protocol designed to directly generate oxygen-centered free radicals by perfusing hearts with a combination of xanthine oxidase (XOD; xanthine: oxygen oxidoreductase, E.C. 1.13.22; Boehringsr Mannheim Biochemicals, Indianapolis, Indiana) and hypoxanthine. 31 As controls, four hearts were perfused with oxygenated control perfusate containing 0.2 mM hypoxanthine (6-hydroxypurine, Sigma) or 0.02 units/ml XOD alone. Five hearts were perfused with a combination of hypoxanthine and XOD. Five additional hearts were perfused with hypoxanthine and XOD with SOD (150 or 500 units/ml) and catalase (500 or 1,000 units/ml) added to the perfusate.
Hypoxanthine was dissolved directly in the perfusate. XOD was dissolved in Krebs-Henseleit buffer at a concentration of 0.40 units/ml and infused with a syringe pump (model 355, Sage, Cambridge, Massachusetts) at 1.0 ml/min through a sidearm located above the aorta to provide a final perfusate concentration of 0.02 units/ml.
Demonstration of superoxide anion formation by the combination of hypoxanthine and XOD was verified with the ferricytochrome c spectrophotometric assay. 32 The rate of absorbance change at 535 nm was monitored with the same concentrations of hypoxanthine, XOD, SOD, and catalase as those used in the perfusate. Neither hypoxanthine nor XOD alone generated detectable superoxide anion, whereas the combination generated 3.07 x 10" 6 mmol/1/min (determined as the SOD inhibitable reduction of cytochrome c). SOD and catalase at the concentrations used in these studies of perfused hearts inhibited formation.
Statistical Analysis
Tissue MDA contents between groups were compared by two-way analysis of variance for multiple comparisons with additional post hoc tests for differences (Bonferroni formulation). Hemodynamic parameters were compared within groups by a paired t analysis. A value of /?<0.05 was accepted as being statistically significant. All values are reported as mean±SD. nmol/g wet wt, respectively (/>=NS and not different compared with MDA content of hearts perfused under control conditions, 0.93 ±0.67 nmol/g). When XOD was infused concomitantly with hypoxanthine, tissue MDA content rose to 18.10 + 5.71 nmol/g wet wt (range 9.63-26.99 nmol/ g wet wt) (/xO.01). In hearts perfused with XOD and hypoxanthine, but also concomitantly with the free radical scavengers SOD and catalase, tissue MDA was reduced to 1.09±0.34 nmol/g wet wt (/><0.01 compared with hearts not treated with SOD and catalase and/?=NS compared with hearts perfused with XOD or hypoxanthine alone). The higher dose of scavengers did not provide any discernible additional benefit. Therefore, in our system, production of tissue MDA was associated with direct oxygen-centered free radical generation and its abolition with scavengers of the oxygencentered free radical system were demonstrable.
Results

Lipid Peroxidation Induced by Perfusion of Hypoxanthine and Xanthine Oxidase
Effects of Ischemia and Reperfusion on Hemodynamics
Hemodynamic data are summarized in Table 1 . Hearts subjected to control perfusion conditions (with or without diltiazem) maintained constant left ventricular pressure and dP/dt throughout the study period. There was no decrease of ventricular performance with diltiazem. All hearts subjected to ischemia exhibited severe reduction of contractile function. Contracture was evident in hearts subjected to reperfusion, and perhaps because the interval of reperfusion was brief, no salutary effect of diltiazem on functional recovery was observed. Two hearts subjected to reperfusion and two hearts subjected to reperfusion with diltiazem manifested fibrillation upon reflow. Performance of these hearts was not different before the onset of fibrillation.
Lipid Peroxidation Induced by Reperfusion
Tissue MDA content for all groups of hearts is shown in Figure 5 . Tissue MDA in nonperfused hearts averaged 0.39±0.32 nmol/g wet wt and increased slightly in hearts subjected to 60 minutes of control perfusion (0.93±0.67 nmol/g, /?=NS). Control hearts treated with diltiazem showed no differences in tissue MDA content in comparison with hearts undergoing control perfusion without drug (0.84±0.77 vs. 0.93±0.67 nmol/g, respectively). Hearts subjected to ischemia did not exhibit an increase in tissue MDA content (0.77±0.99 nmol/g). In contrast, hearts subjected to 3 minutes of reperfusion showed a more than threefold increase in tissue MDA content (3.57±1.88 nmol/g). In none of these hearts could MDA be detected in the pulmonary effluent. The increase in tissue MDA content observed in reperfused hearts was attenuated by diltiazem (1.54±1.09 nmol/g). However, the increased MDA content observed in hearts subjected to reperfusion was not attenuated by treatment with SOD or catalase (MDA content, 3.88±2.28 nmol/g) at doses shown to ameliorate MDA production in validation studies in which free radicals were generated directly. Excluding hearts with reperfusion arrhythmias did not alter the results.
Discussion
Recent studies of reperfusion injury have focused on the formation of oxygen-centered free radicals as a mechanism of tissue damage militating against full tissue sab/age. 8 -13 Indirect evidence for this has included protection of myocardium by radical scavengers and inhibitors of radical generating enzymes. 10 -12 More direct evidence has been derived from direct demonstration of oxygen-centered free radicals by electron-spin resonance spectroscopy of spin-labeled compounds in coronary effluent and by direct observation of oxygen-and carbon-centered free radical formation in reperfused myocardium by electron paramagnetic spectroscopy. 9 ' 13 However, the interpretation of these results has recently been questioned, 14 ' 15 -18 and the finding of oxygencentered free radicals in tissue per se may not necessarily imply cytotoxic effects.
MDA, a lipid peroxidation product, has been used as a marker of lipid peroxidation. 12 ' 20 The rationale behind measurement of MDA is that free radicals may attack conjugated methylene groups on polyunsaturated fatty acids in a nonenzymatic reaction forming lipid radicals and hydroperoxides. 19 The hydroperoxides undergo conformational rearrangements and participate in free radical chain reactions to fragment into MDA (a three-carbon compound). Thus, measurement of MDA in tissue could provide an index of tissue lipid injury due to peroxidation by free radicals. In addition, MDA is Vahies represent mean±SD. SP, left ventricular systolic pressure (mm Hg); DP, left ventricular diastolic pressure (mm Hg); dP/dt, first derivative of SP (mm Hg/sec); N/A, not applicable; . . ., no SP or dP/dt could be measured. *p<0.01 compared with baseline value. tp<0.001 compared with baseline value. 002 compared with baseline value.
known to be a direct toxic agent, and its presence may increase tissue injury. 33 Previous studies have used a TBA colorimetric assay to demonstrate MDA production within in vitro and in vivo systems. 12 ' 20 Some investigators have observed increased serum MDA levels with the TBA assay in patients with myocardial ischemia. 34 However, many substances released by tissue, such as sialic acid and bile pigments, can interfere with the TBA-MDA reaction. 19 -29 -30 Because of this, the method has been criticized as variable and nonspecific. In fact, measurement of lipid peroxides in serum by the TBA method yields levels that are higher than those that are physiologically tolerable. 35 The sensitivity of HPLC for detection of MDA generated directly by free radicals was assessed by perfusing rabbit hearts with hypoxanthine and XOD in combination, a system that has been previously shown to generate oxygen-centered free radicals. 31 -32 As reported previously, perfusion with the combination of XOD and hypoxanthine produces ultrastructural damage, hemodynamic deterioration, and membrane permeability changes. 31 In our study, tissue MDA was significantly elevated under conditions of XOD-hypoxanthine perfusion (Figure 4 ). This increase was completely blocked by the presence of SOD and catalase, specific free radical scavengers, in the perfusate thereby implying a free radical-mediated mechanism. MDA production was presumably induced by generation of oxygen radical species in the intravascular space and diffusion of superoxide anion and hydrogen peroxide into endothelium or myocardial tissue. The conversion of these radicals to the highly toxic hydroxyl radicals via Fenton and Haber-Weiss reactions is thought to be a direct mechanism of tissue injury. 19 Tissue MDA content in nonperfused hearts and in isolated hearts perfused for 1 hour under control conditions show minimal levels of MDA. Profound ischemia of 60 minutes did not produce a significant lipid peroxidation as assessed by MDA content. However, after 3 minutes of reperfusion, there was a threefold increase in MDA content. We observed an elevation in MDA content in reperfused, but not in ischemic, hearts. This observation lends further support to the hypothesis that reperfusion is associated with specific pathophysiological mechanisms (such as lipid peroxidation) that, though dependent on antecedent ischemia, may accelerate or compound the injury of ischemia.
The elevation of tissue MDA during reperfusion was not prevented or blunted by SOD and catalase. In contrast, in our validation studies, we demonstrated that, when free radicals were directly generated intravascularry (using a combined infusion of XOD and hypoxanthine), production of presumably free radical-induced lipid peroxidation was completely attenuated by SOD and catalase. This observation suggests that free radical production in reperfused tissue may be an intracellular process not accessible to high molecular weight free radical scavengers. Potential sources of intracellular oxygencentered free radicals in ischemic tissue may include damaged mitochondria and arachidonate metabolism. Damage to the mitochondrial membrane and the respiratory enzyme chain may be important determinants of injury during ischemia and reperfusion. Disrupted mitochondria are known to be a source of free radical release after ischemia. 36 Enhanced release of free radicals by damaged mitochondria into a cellular matrix already depleted of SOD, catalase, and glutathione peroxidase during ischemia may increase peroxidative membrane injury. 20 In addition, arachidonic acid is released by calcium-activated phospholipases after reperfusion. 37 The metabolism of arachidonate by cycloxygenases and lipoxygenases in the presence of reducing substances, known to be elevated in ischemia, has been shown to result in superoxide anion release. 38 Although evidence suggests lipoxygenase is not present in myocytes, 39 endothelium possesses both cycloxygenase and lipoxygenase activity.
Treatment of hearts with diltiazem reduced the production of MDA seen with reperfusion. Diltiazem, but not SOD and catalase, has been shown to prevent microvascular permeability changes and ventricular function deterioration in a similar isolated heart preparation. 40 Diltiazem has also been shown to protect myocardium from ischemic injury as well as to enhance salvage with reperfusion. 2 -5 These salutary effects in vivo may reflect favorable alterations of hemodynamics and myocardial blood flow as well as direct cytoprotective mechanisms. The concentration of diltiazem used in the present study was selected to detect nonhemodynamic, cytoprotective effects. The mechanisms responsible for diltiazem's protective effect with reperfusion may depend on a relative reduction of cellular calcium influx or mobilization from intracellular stores. Reoxygenation after prolonged ischemia is associated with a significant influx of calcium. 7 In mitochondria, calcium accumulation and precipitation can alter membrane lipid organization and respiratory chain function, 7 -41 which may promote release of oxygencentered free radicals. Diltiazem is known to preserve mitochondrial function during reperfusion 6 and may therefore attenuate this process.
The reduction of calcium-activated phospholipase activity may prevent formation of arachidonate, which can be a source of free radical production through enzymatic metabolism in addition to being a source of MDA formation itself because of its quadruple conjugated-methylene structure. Results from studies with coronary endothelial cell cultures suggest that calcium-channel blockers, including diltiazem, can inhibit calcium-stimulated prostaglandin synthesis/ 2 Accordingly, reduction of intracellular calcium concentrations by diltiazem may reduce free radical-generating mechanisms and lipid peroxidation.
An alternative consideration for the relative reduction in MDA with diltiazem may be that lipid peroxidation does not precede, but is a manifestation of, myocardial tissue injury. Under such circumstances, the reduction of MDA production may simply reflect preservation of myocardial tissue by diltiazem rather than direct inhibition of lipid peroxidation. Finally, since diltiazem attenuated MDA production in reperfused tissue but scavengers of free radicals did not, it is possible that lipid peroxidation occurring with reperfusion may be mediated by non-free radical pathways. Such mechanisms presumably operate through calcium sensitive pathways.
The results of the present study indicate that in isolated perfused rabbit hearts, in which blood cells and XOD activity are excluded as sources of oxygencentered free radicals, lipid peroxidation occurs with reperfusion but not with ischemia alone. Diltiazem reduced MDA formation. In contrast, SOD and catalase did not prevent formation of lipid peroxides with reperfusion. This occurrence suggests that lipid peroxidation may have been due to formation of oxygen-centered free radicals not accessible to the scavengers but by calcium sensitive mechanisms. Alternatively, diltiazem may attenuate lipid peroxidation directly due to cytoprotective mechanisms thereby conferring protective effects in the setting of reperfusion.
